Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Mar 31;12(3):684-687.
doi: 10.21037/tcr-22-2790. Epub 2023 Feb 20.

Tumor human papillomavirus: a potential test for cervical cancer prognosis

Tan Minh Le  1   2 , Gun Oh Chong  3   4 , Hyung Soo Han  1   2   3   5
Affiliations
Editorial

Tumor human papillomavirus: a potential test for cervical cancer prognosis

Tan Minh Le et al. Transl Cancer Res. .
No abstract available

Keywords: RNA sequencing (RNAseq); Tumor human papillomavirus test (tumor HPV test); cervical cancer (CC); high-risk HPV.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-22-2790/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Tabibi T, Barnes JM, Shah A, et al. Human Papillomavirus Vaccination and Trends in Cervical Cancer Incidence and Mortality in the US. JAMA Pediatr 2022;176:313-6. 10.1001/jamapediatrics.2021.4807 - DOI - PMC - PubMed
    1. Zhang J, Zhao Y, Dai Y, et al. Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical Trial. JAMA Oncol 2021;7:263-70. 10.1001/jamaoncol.2020.6575 - DOI - PMC - PubMed
    1. WHO. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition: use of mRNA tests for human papillomavirus (HPV). 2021. Available online: https://www.who.int/publications/i/item/9789240030824 - PubMed
    1. Pilch H, Günzel S, Schäffer U, et al. The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University. Int J Gynecol Cancer 2001;11:39-48. 10.1046/j.1525-1438.2001.011001039.x - DOI - PubMed
    1. Füle T, Csapó Z, Máthé M, et al. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes. Gynecol Oncol 2006;100:570-8. 10.1016/j.ygyno.2005.09.019 - DOI - PubMed